A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Ganetespib|DRUG: Paclitaxel|DRUG: Doxorubicin|DRUG: Cyclophosphamide
Sponsor: University of Chicago